Navigation Links
New treatment for diabetics

A researcher from America has developed a micro capsule coated with silicon, which could save the diabetics from the usual insulin injection.This microchip works by absorbing nutrients from the body //and stimulates the insulin- producing cells.Some diabetics have to inject insulin more than onece a day to maintain their blood sugar levels.

The device is being developed by Tejal Desai of the University of Illinois at Chicago Ms Desai, who presented her findings to a meeting of the American Vacuum Society in San Francisco, said: "The capsule essentially acts as a bioreactor - it contains insulin-secreting cells that borrow nutrients from the body to keep producing insulin indefinitely. "As long as the body produces glucose, the cells will respond with insulin."

There are two types of diabetes. Type 1 is known as insulin-dependent diabetes. It destroys the cells in the pancreas that produce the hormone insulin, needed to control blood sugar levels. It usually develops early in life, and sufferers may need at least one insulin injection every day.

Type 2, or non-insulin dependent diabetes is the most common form of the disease, and usually affects people later in life. Patients with the condition do not make enough insulin, or cannot use it properly, which means they cannot move blood sugar into the cells. Sugar then builds up in the bloodstream and causes health problems. Type 2 diabetes can be controlled by regular exercise and diet control, though some also need extra insulin. However Desai sad that it will need a lot more testing before diabetic patients can use it.


'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New treatment for diabetics

(Date:12/4/2009)..., , PEMBROKE, Bermuda, Dec. 4 /PRNew... Holdings, Ltd (NYSE: AWH ) today announced that...ficer, and Jack Sennott, Executive Vice,President ...enting at the 2009,Goldman Sachs U.S. Financial Se...Conference Center in New York City on Tuesday, Dec...
(Date:12/4/2009)..., , ANAHEIM, Calif., Dec. 4 /PRNewswire/...scent Healthcare, was selected as a finalist for t...forming Crescent,s business with the power of clou...ased on their innovative usage of Salesforce CRM o... customer success to their sales, marketing, partn...
(Date:12/4/2009)..., Working with mice, scientists at Johns Hopkins...ave shown that a protein made by a gene called "Tw...ately distinguish stem cells that drive aggressive...r cells. , Building on recent work suggesting th...in breast tumors that drives breast cancer, scient...
(Date:12/4/2009)...Outcomes same whether procedure done immediately o... Dec. 4 (HealthDay News) -- Timing of surgical rep...juries may not affect patient outcome, a new study...esult from traumatic knee dislocations that can oc...s. The optimal time to perform surgery to repair t...
(Date:12/4/2009)...Research and surveillance urged for at-risk patien...ews) -- Some childhood cancers, particularly Ewing... the risk of late recurrence, U.S. researchers hav... 12,795 five-year survivors of the most common ped...Cancer Survivor Study. , The researchers found ...
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...nder 25 remains unclear, researchers say , ...erotonin reuptake inhibitors (SSRIs) may significa...cide in depressed adults, according to a review of...e World Health Organization and the University of ...
...y associated with muscle power and force in adoles...publication in The Endocrine Society,s Journal of... Although vitamin D is naturally produced in the b...ve a significant negative impact on muscle and bon...
...hnologies, Inc. ("Senesco" or the "Company") (NYSE...f efficacy, toxicological and dose-finding studies...andidate, SNS-01. SNS-01 is a nano-encapsulated c...asibility of long-term intravenous administration ...
...educe cravings, hunger levels, appetite, and food ... 3 Nutrition 21, Inc. (Nasdaq: NXXI ), the deve...r the Iceland Health(R) brand launched a potential...cted to reduce cravings, hunger levels, appetite, ...
... reduced overall death rates of patients hospitali... Hospital readmission rates for heart patients al...or hospital admissions in Virginia, and heart dise....vhi.org -- with quality comparisons among all Vi...
...gg producers are,unveiling "Incredible People," a ...the incredible edible egg(TM). The campaign remind...tein in the eggs they love provides them with,the ...n," said Kevin Burkum, senior vice president,of ma...
Other Medicine News:Health News:SSRI Antidepressants May Lower Adult Suicide Risk 2Health News:Vitamin D tied to muscle power in adolescent girls 2Health News:Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate 2Health News:Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate 3Health News:Senesco Announces Results of Pre-Clinical Efficacy, Toxicology and Dose Ranging Studies for Multiple Myeloma Therapeutic Candidate 4Health News:Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) 'Appetite Control Formula' 2Health News:Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) 'Appetite Control Formula' 3Health News:Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) 'Appetite Control Formula' 4Health News:Virginia Hospitals Improve Heart Care--Death & Readmission Rates Decline 2Health News:America's Egg Farmers Launch New Incredible Edible Egg(TM) Advertising Campaign Focusing on 'Body And Mind' 2Health News:America's Egg Farmers Launch New Incredible Edible Egg(TM) Advertising Campaign Focusing on 'Body And Mind' 3
(Date:12/3/2009)... , , MADISON, N.J., Dec. 3 /PRNewswire-F... a patient,s risk of developing a potentially life...pharmaceutical therapies or chemicals is one of se...gnostics leader Quest Diagnostics (NYSE: DGX ) w...matology (ASH) Annual Meeting and Exposition, Dece...
(Date:12/3/2009)... , , DOYLESTOWN, Pa., Dec. 3 /PRNew...f The Quigley Corporation, (Nasdaq: QGLY ) www.q... completed its evaluation of its opportunities to ...ts and has concluded that it is in its best intere...rketplace, which may include but are not limited t...
(Date:12/3/2009)... , , WARRENDALE, Pa., Dec. 3 /P.... demonstrated PACS* injection-record integration ...y of North America in Chicago. The Connect.PACS(...tics capabilities of its kind, is the latest relea...formatics Platform . ,, (Photo: http://www....
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3SXC Health solutions announces record third quarter financial results 60754 1SXC Health solutions announces record third quarter financial results 60754 2SXC Health solutions announces record third quarter financial results 60754 3SXC Health solutions announces record third quarter financial results 60754 4SXC Health solutions announces record third quarter financial results 60754 5SXC Health solutions announces record third quarter financial results 60754 6SXC Health solutions announces record third quarter financial results 60754 7SXC Health solutions announces record third quarter financial results 60754 8SXC Health solutions announces record third quarter financial results 60754 9SXC Health solutions announces record third quarter financial results 60754 10SXC Health solutions announces record third quarter financial results 60754 11SXC Health solutions announces record third quarter financial results 60754 12SXC Health solutions announces record third quarter financial results 60754 13SXC Health solutions announces record third quarter financial results 60754 14SXC Health solutions announces record third quarter financial results 60754 15SXC Health solutions announces record third quarter financial results 60754 16SXC Health solutions announces record third quarter financial results 60754 17SXC Health solutions announces record third quarter financial results 60754 18SXC Health solutions announces record third quarter financial results 60754 19SXC Health solutions announces record third quarter financial results 60754 20Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 1Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 2Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 3Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 4Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 5Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 6Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 7Stereotaxis Reports 26 25 Third Quarter 2009 Revenue Growth 60749 8BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 1BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 4
...ld-Standard for Renal Cell Carcinoma in 2012, Acco... WALTHAM, Mass., Feb. 26 Decision Resources, one ... for pharmaceutical and healthcare issues, finds t... carcinoma that can increase overall survival in c...cent patient share in the United States and a 35 p...
...Alternext: ALEHT) is pleased to announce that clin...eimer,s disease, is progressing well. Patient,enro...n patients with,Alzheimer,s disease is completed. ...ent for the Phase IIa,represents an important mile... a clear timeline for the release of results," sta...
Other Medicine Technology:A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe 2A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4
...YDON is a long-pulsed Nd:YAG laser system with a w...deep-lying, superficial as well as red and blue ve...pilation in patients with darker skin types (1 to ...vement of skin texture. The handpieces special des...
...he UroVysion Bladder Cancer Kit (UroVysion Kit) is...7, 17, and loss of the 9p21 locus via fluorescence...rom persons with hematuria suspected of having bla...tended for use, in conjunction with and not in lie...
The BTA TRAK® Assay
ARION Long-Pulsed Alexandrite Laser System
Medicine Products: